PHAT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $30,815,661.94

Phathom Pharmaceuticals Insider Trading History Chart

Phathom Pharmaceuticals Share Price & Price History

^$8.78

▼ -0.31 (-3.41%)

As of 11/15/2024 01:00 AM ET

Days: 30 | 90 | 365

“Amazon Coin” set to outperform Bitcoin

From True Market Insiders | Ad

Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…

#1 FREE Crypto for 2024

Phathom Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/15/2024	Azmi Nabulsi	COO	Sell	10,901	$11.72	$127,759.72	240,421
7/15/2024	Molly Henderson	CFO	Sell	4,325	$11.72	$50,689.00	99,447
7/15/2024	Terrie Curran	Insider	Sell	33,848	$11.72	$396,698.56	377,734
4/8/2024	Molly Henderson	CFO	Sell	3,435	$11.10	$38,128.50	95,263
3/22/2024	Terrie Curran	Insider	Sell	16,851	$9.11	$153,512.61	410,784
1/24/2024	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	3,703,703	$8.10	$29,999,994.30	3,755,583
1/19/2024	Molly Henderson	CFO	Sell	6,307	$7.75	$48,879.25	98,698
11/8/2023	Asit Parikh	Director	Buy	2,500	$7.80	$19,500.00	55,000
11/6/2023	Asit Parikh	Director	Buy	1,000	$8.04	$8,040.00	48,500
11/1/2023	Molly Henderson	CFO	Sell	12,492	$8.88	$110,928.96	105,188
6/2/2023	Molly Henderson	CFO	Sell	1,960	$11.41	$22,363.60	68,506
5/22/2023	Molly Henderson	CFO	Sell	2,110	$12.87	$27,155.70	70,466
4/11/2023	Azmi Nabulsi	COO	Buy	10,000	$8.26	$82,600.00	99,567
4/10/2023	Asit Parikh	Director	Buy	1,000	$7.55	$7,550.00	23,500
4/6/2023	Molly Henderson	CFO	Sell	3,439	$7.27	$25,001.53	72,576
4/6/2023	Terrie Curran	Insider	Buy	12,919	$7.82	$101,026.58	188,290
3/1/2023	Molly Henderson	CFO	Sell	2,032	$8.53	$17,332.96	76,015
3/1/2023	Terrie Curran	Insider	Sell	1,436	$8.54	$12,263.44	175,371
2/13/2023	Asit Parikh	Director	Buy	5,000	$7.73	$38,650.00	22,500
1/20/2023	Terrie Curran	Insider	Sell	5,821	$8.20	$47,732.20	176,807
1/12/2023	Asit Parikh	Director	Buy	5,000	$7.00	$35,000.00	17,500
5/16/2022	Azmi Nabulsi	COO	Buy	20,000	$8.16	$163,200.00	785,700
5/13/2022	Terrie Curran	Insider	Buy	20,500	$7.41	$151,905.00	64,595
5/12/2022	Asit Parikh	Director	Buy	12,500	$8.00	$100,000.00	12,500
3/14/2022	Pharmaceutical Co Ltd Takeda	Major Shareholder	Sell	18	$19.00	$342.00

Bill Gates’ is about to mint millionaires (again) with Stargate.

From Brownstone Research | Ad

Click here and I’ll tell you everything you need to know.

SEC Filings (Institutional Ownership Changes) for Phathom Pharmaceuticals (NASDAQ:PHAT)

99.01% of Phathom Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Phathom Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	862,918	$15.61M	0.0%	+7.1%	1.262%
11/15/2024	Barclays PLC	57,807	$1.04M	0.0%	+366.0%	0.085%
11/15/2024	MML Investors Services LLC	33,860	$0.61M	0.0%	+72.8%	0.050%
11/15/2024	Jane Street Group LLC	27,842	$0.50M	0.0%	-50.1%	0.041%
11/15/2024	Wellington Management Group LLP	173,383	$3.14M	0.0%	-23.5%	0.254%
11/15/2024	State Street Corp	922,788	$16.68M	0.0%	+17.5%	1.349%
11/15/2024	Point72 Asset Management L.P.	439,816	$7.95M	0.0%	N/A	0.643%
11/15/2024	Portolan Capital Management LLC	1,699,918	$30.74M	2.2%	+50.4%	2.486%
11/15/2024	Checkpoint Capital L.P.	1,504,307	$27.20M	13.5%	+71.9%	2.200%
11/14/2024	Wasatch Advisors LP	246,942	$4.47M	0.0%	N/A	0.361%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	98,025	$1.77M	0.0%	+5.2%	0.143%
11/13/2024	FMR LLC	1,304,114	$23.58M	0.0%	+49,000.7%	1.907%
11/13/2024	Summit Financial Wealth Advisors LLC	29,032	$0.53M	0.1%	N/A	0.042%
11/12/2024	Eagle Asset Management Inc.	455,196	$7.68M	0.0%	+25.9%	0.764%
11/12/2024	Charles Schwab Investment Management Inc.	292,860	$5.30M	0.0%	+2.4%	0.491%
11/9/2024	Intech Investment Management LLC	11,443	$0.21M	0.0%	N/A	0.019%
11/8/2024	Jennison Associates LLC	5,866,389	$106.06M	0.1%	+112.7%	9.845%
11/7/2024	Quest Partners LLC	10,918	$0.20M	0.0%	N/A	0.018%
11/6/2024	Huntington National Bank	1,471	$27K	0.0%	+62.2%	0.002%
11/5/2024	GSA Capital Partners LLP	15,083	$0.27M	0.0%	-48.7%	0.025%
11/4/2024	Chartwell Investment Partners LLC	21,904	$0.40M	0.0%	N/A	0.037%
10/28/2024	US Bancorp DE	5,248	$95K	0.0%	+28.6%	0.009%
10/25/2024	China Universal Asset Management Co. Ltd.	13,134	$0.24M	0.0%	+91.0%	0.022%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,470	$43K	0.0%	+41.3%	0.004%
10/11/2024	Creative Planning	33,884	$0.61M	0.0%	+25.7%	0.057%
10/3/2024	SG Americas Securities LLC	13,483	$0.24M	0.0%	N/A	0.023%
8/16/2024	Creative Planning	26,951	$0.28M	0.0%	-16.0%	0.045%
8/15/2024	The Manufacturers Life Insurance Company	13,941	$0.14M	0.0%	+10.6%	0.023%
8/14/2024	Oracle Investment Management Inc.	225,000	$2.32M	2.2%	N/A	0.378%
8/14/2024	Marshall Wace LLP	112,691	$1.16M	0.0%	N/A	0.193%
8/13/2024	Ensign Peak Advisors Inc	2,244,828	$23.12M	0.0%	-1.5%	3.835%
8/1/2024	Rhumbline Advisers	55,178	$0.57M	0.0%	+17.1%	0.094%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	10,071	$0.10M	0.0%	+42.2%	0.017%
7/26/2024	Bank of New York Mellon Corp	114,721	$1.18M	0.0%	+20.5%	0.196%
7/16/2024	LVW Advisors LLC	12,909	$0.13M	0.0%	N/A	0.022%
7/13/2024	Inspirion Wealth Advisors LLC	36,634	$0.38M	0.1%	+4.3%	0.063%
5/16/2024	California State Teachers Retirement System	28,947	$0.31M	0.0%	-5.4%	0.049%
5/16/2024	Jacobs Levy Equity Management Inc.	20,987	$0.22M	0.0%	-96.5%	0.036%
5/15/2024	Price T Rowe Associates Inc. MD	19,573	$0.21M	0.0%	+12.5%	0.033%
5/14/2024	EntryPoint Capital LLC	19,380	$0.21M	0.2%	N/A	0.033%
5/14/2024	Propel Bio Management LLC	869,927	$9.24M	5.1%	+96.4%	1.486%
5/10/2024	Vanguard Group Inc.	1,979,113	$21.02M	0.0%	+1.2%	3.382%
5/9/2024	State Board of Administration of Florida Retirement System	11,228	$0.12M	0.0%	N/A	0.019%
5/8/2024	Entropy Technologies LP	12,138	$0.13M	0.0%	-16.8%	0.021%
5/2/2024	Jennison Associates LLC	1,647,697	$17.50M	0.0%	N/A	2.816%
5/1/2024	Klingman & Associates LLC	10,376	$0.11M	0.0%	N/A	0.018%
4/29/2024	China Universal Asset Management Co. Ltd.	10,989	$0.12M	0.0%	+65.8%	0.019%
4/15/2024	Medicxi Ventures Management Jersey Ltd	7,464,572	$79.27M	17.6%	+98.5%	12.764%
3/5/2024	Wellington Management Group LLP	154,391	$1.41M	0.0%	+54.7%	0.270%
2/15/2024	Octagon Capital Advisors LP	50,000	$0.46M	0.1%	N/A	0.087%
2/14/2024	Avidity Partners Management LP	1,721,580	$15.72M	0.6%	+6.4%	3.007%
2/14/2024	Catalys Pacific LLC	721,962	$6.59M	6.2%	N/A	1.261%
2/12/2024	Decheng Capital LLC	850,000	$7.76M	2.2%	N/A	1.485%
2/9/2024	GW&K Investment Management LLC	561,490	$5.13M	0.0%	-2.8%	0.981%
2/9/2024	Dynamic Technology Lab Private Ltd	15,000	$0.14M	0.0%	N/A	0.026%
2/6/2024	Swiss National Bank	56,000	$0.51M	0.0%	-7.0%	0.098%
2/5/2024	Russell Investments Group Ltd.	39,292	$0.36M	0.0%	+178.3%	0.069%
2/2/2024	Fulton Breakefield Broenniman LLC	23,579	$0.22M	0.0%	N/A	0.041%
1/24/2024	Allworth Financial LP	22,580	$0.21M	0.0%	+15.3%	0.039%
1/24/2024	China Universal Asset Management Co. Ltd.	6,626	$60K	0.0%	+355.4%	0.012%
1/23/2024	DAVENPORT & Co LLC	10,000	$91K	0.0%	N/A	0.017%
1/12/2024	SG Americas Securities LLC	18,070	$0.17M	0.0%	+48.6%	0.032%
1/10/2024	Inspirion Wealth Advisors LLC	35,134	$0.32M	0.1%	+16.6%	0.061%
12/19/2023	Public Employees Retirement System of Ohio	8,900	$92K	0.0%	N/A	0.016%
12/18/2023	Vanguard Group Inc.	1,922,662	$19.94M	0.0%	+10.3%	3.358%
12/6/2023	Citigroup Inc.	3,828	$40K	0.0%	-57.9%	0.007%
12/1/2023	Wellington Management Group LLP	99,810	$1.04M	0.0%	+1.8%	0.174%
11/15/2023	GSA Capital Partners LLP	121,892	$1.26M	0.1%	+126.1%	0.213%
11/15/2023	Kennedy Capital Management LLC	1,061,745	$11.01M	0.3%	+1.1%	1.855%
11/14/2023	683 Capital Management LLC	1,100,000	$11.41M	0.9%	-14.6%	1.921%
11/14/2023	MPM Bioimpact LLC	347,332	$3.60M	1.0%	+23.0%	0.607%
11/14/2023	Newtyn Management LLC	500,000	$5.19M	1.3%	-26.9%	0.873%
11/14/2023	Avidity Partners Management LP	1,617,300	$16.77M	0.7%	-17.0%	2.825%
11/14/2023	Trexquant Investment LP	58,825	$0.61M	0.0%	+221.4%	0.103%
11/13/2023	Algert Global LLC	91,820	$0.95M	0.0%	N/A	0.160%
11/13/2023	Federated Hermes Inc.	82,148	$0.85M	0.0%	-49.9%	0.143%
11/13/2023	Invesco Ltd.	3,418,959	$35.46M	0.0%	+2.6%	5.972%
11/8/2023	Swiss National Bank	60,200	$0.62M	0.0%	-15.8%	0.106%
11/7/2023	Barclays PLC	13,235	$0.14M	0.0%	+22.4%	0.023%
11/2/2023	Principal Financial Group Inc.	11,801	$0.12M	0.0%	+11.9%	0.021%
10/27/2023	Hennion & Walsh Asset Management Inc.	48,987	$0.51M	0.0%	-16.5%	0.086%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	8,429	$87K	0.0%	+371.4%	0.015%
10/24/2023	Bank of New York Mellon Corp	95,065	$0.99M	0.0%	+21.0%	0.167%
10/13/2023	SG Americas Securities LLC	12,164	$0.13M	0.0%	N/A	0.021%
9/21/2023	Barclays PLC	10,813	$0.16M	0.0%	-13.7%	0.019%
8/15/2023	Kennedy Capital Management LLC	1,049,675	$15.03M	0.4%	N/A	2.407%
8/14/2023	683 Capital Management LLC	1,287,500	$18.44M	1.3%	-2.9%	2.952%
8/11/2023	Trexquant Investment LP	18,301	$0.26M	0.0%	N/A	0.042%
8/8/2023	AlphaCentric Advisors LLC	130,000	$1.86M	1.0%	N/A	0.298%
8/7/2023	Principal Financial Group Inc.	10,542	$0.15M	0.0%	N/A	0.024%
8/4/2023	Carlyle Group Inc.	3,496,808	$50.07M	1.8%	+19.1%	8.018%
7/28/2023	Decheng Capital Management III Cayman LLC	850,000	$12.17M	3.8%	N/A	1.949%
7/20/2023	Inspirion Wealth Advisors LLC	30,134	$0.43M	0.1%	+29.6%	0.069%
7/19/2023	Medicxi Ventures Management Jersey Ltd	3,760,869	$53.86M	15.1%	+51.4%	8.624%
5/15/2023	Atom Investors LP	86,607	$0.62M	0.3%	N/A	0.199%
5/10/2023	Simplify Asset Management Inc.	237,935	$1.70M	0.2%	N/A	0.546%
5/9/2023	GW&K Investment Management LLC	598,848	$4.28M	0.0%	+0.8%	1.374%
5/5/2023	Carlyle Group Inc.	2,935,106	$20.87M	0.6%	N/A	6.732%
4/28/2023	SG Americas Securities LLC	11,328	$81K	0.0%	N/A	0.026%
4/27/2023	Stratos Wealth Advisors LLC	12,500	$89K	0.0%	N/A	0.029%

Data available starting January 2016

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Today's Range

Now: $8.78

$8.54

$9.30

50 Day Range

MA: $16.58

$8.78

$19.50

52 Week Range

Now: $8.78

$6.07

$19.71

Volume

2,157,100 shs

Average Volume

904,750 shs

Market Capitalization

$600.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.72

Who are the company insiders with the largest holdings of Phathom Pharmaceuticals?: Phathom Pharmaceuticals' top insider shareholders include:
Pharmaceutical Co Ltd Takeda (Major Shareholder)
Terrie Curran (Insider)
Azmi Nabulsi (COO)
Molly Henderson (CFO)
Asit Parikh (Director)
Learn More about top insider investors at Phathom Pharmaceuticals.
Who are the major institutional investors of Phathom Pharmaceuticals?: Phathom Pharmaceuticals' top institutional shareholders include:
Jennison Associates LLC — 9.84%
Portolan Capital Management LLC — 2.49%
Checkpoint Capital L.P. — 2.20%
FMR LLC — 1.91%
State Street Corp — 1.35%
Geode Capital Management LLC — 1.26%
Learn More about top institutional investors of Phathom Pharmaceuticals stock.
Which major investors are selling Phathom Pharmaceuticals stock?: Within the previous quarter, PHAT stock was sold by these institutional investors:
Wellington Management Group LLP
Jane Street Group LLC
GSA Capital Partners LLP
In the last year, company insiders that have sold Phathom Pharmaceuticals company stock include:
Pharmaceutical Co Ltd Takeda (Major Shareholder)
Terrie Curran (Insider)
Azmi Nabulsi (COO)
Molly Henderson (CFO)
Learn More investors selling Phathom Pharmaceuticals stock.
Which major investors are buying Phathom Pharmaceuticals stock?: Within the previous quarter, PHAT stock was acquired by institutional investors including:
Jennison Associates LLC
FMR LLC
Checkpoint Capital L.P.
Portolan Capital Management LLC
Point72 Asset Management L.P.
Wasatch Advisors LP
State Street Corp
Eagle Asset Management Inc.
During the last year, these company insiders have bought Phathom Pharmaceuticals stock:
Pharmaceutical Co Ltd Takeda (Major Shareholder)
Terrie Curran (Insider)
Azmi Nabulsi (COO)
Learn More investors buying Phathom Pharmaceuticals stock.